#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products


article has not abstract


Vyšlo v časopise: Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products. PLoS Med 6(7): e32767. doi:10.1371/journal.pmed.1000118
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000118

Souhrn

article has not abstract


Zdroje

1. YangJS

NovotnyTE

2009 Policy coherence in US tobacco control: Beyond FDA regulation. PLoS Med 6 e1000079 doi:10.1371/journal.pmed.1000079

2. GivelM

GlantzSA

2004 The “global settlement” with the tobacco industry: 6 years later. Am J Public Health 94 218 224

3. FoxBJ

LightwoodJM

GlantzSA

1998 A public health analysis of the proposed resolution of [the 1997 United States] tobacco litigation. Available: http://repositories.cdlib.org/ctcre/tcpmus/US1998. Accessed 25 June 2009

4. WagnerS

1971 Cigarette country; Tobacco in American history and politics New York Praeger

5. BrandtAM

2007 The cigarette century New York Basic Books

6. BorlandR

YongHH

WilsonN

FongGT

HammondD

2009 How reactions to cigarette packet health warnings influence quitting: Findings from the ITC four-country survey. Addiction 104 669 675

7. Campaign for Tobacco-Free Kids 2009 FDA regulation of tobacco products: A common-sense plan to protect kids and save lives. Available: http://www.lungusa.org/atf/cf/%7B7a8d42c2-fcca-4604-8ade-7f5d5e762256%7D/FDA_BILL_SUMMARY.PDF. Accessed 25 June 2009

8. US Department of Health and Human Services 1989 Reducing the health consequences of smoking: 25 years of progress. A Report of the Surgeon General. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411. Available: http://profiles.nlm.nih.gov/NN/B/B/X/S/. Accessed 25 June 2009

9. SiegelM

CarolJ

JordanJ

HobartR

SchoenmarklinS

1997 Preemption in tobacco control: Review of an emerging public health problem. JAMA 278 858 863

10. NovotnyTE

ZhaoF

1999 Consumption and production waste: Another externality of tobacco use. Tob Control 8 75 80

11. BarkerKG

2009 Thank you for regulating: Why Philip Morris's embrace of FDA regulation helps the company but harms the agency. Admin Law Rev 61 197 224

12. McDanielPA

MaloneRE

2005 Understanding Philip Morris's pursuit of US government regulation of tobacco. Tob Control 14 193 200

13. McDanielPA

SmithEA

MaloneRE

2006 Philip Morris's Project Sunrise: Weakening tobacco control by working with it. Tob Control 15 215 223

14. BerlindMH

1998 Design, manufacturing and marketing of tobacco products: Towards a sensible regulatory framework. Philip Morris. Available: http://legacy.library.ucsf.edu/tid/lgs32a00. Accessed 25 June 2009

15. GoldmanL

GlantzS

1994 Evaluation of antismoking advertising campaigns. JAMA 279 772 777

16. FarrellyMC

HealtonCG

DavisKC

MesseriP

HerseyJC

2002 Getting to the truth: Evaluating national tobacco countermarketing campaigns. Am J Public Health 92 901 907

17. FarrellyMC

DavisKC

HavilandML

MesseriP

HealtonCG

2005 Evidence of a dose-response relationship between “truth” antismoking ads and youth smoking prevalence. Am J Public Health 95 425 431

18. FarrellyMC

NonnemakerJ

DavisKC

HussinA

2009 The influence of the national truth campaign on smoking initiation. Am J Prev Med 36 379 384

19. LingPM

NeilandsTB

GlantzSA

2007 The effect of support for action against the tobacco industry on smoking among young adults. Am J Pub Health 97 1449 1456

20. LingPM

NeilandsTB

GlantzSA

2009 Factors associated with young adult smoking behavior: A national survey. Am J Prev Med 36 389 394

21. GiovinoGA

SidneyS

GfroererJC

O'MalleyPM

AllenJA

2004 Epidemiology of menthol cigarette use. Nicotine Tob Res 6 S67 S81

22. GlantzSA

BarnesDE

BeroL

HanauerP

SladeJ

1996 The cigarette papers Berkeley University of California Press 219 224

23. United States District Court for the District of Columbia 2006 United States v. Philip Morris USA, Inc., et al. 449 F.Supp. 2d 1 (D.D.C. 2006). Available: http://library.ucsf.edu/tobacco/litigation/uspm.html. Accessed 25 June 2009

24. BarnesD

BeroLA

1996 Industry-funded research and conflict of interest: An analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law 21 515 542

25. BarnesD

BeroLA

1997 Scientific quality of original research articles on environmental tobacco smoke. Tob Control 6 19 26

26. BarnesD

BeroLA

1998 Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279 1566 1570

27. BarnesD

HanauerP

SladeJ

BeroLA

GlantzS

1995 Environmental tobacco smoke. The Brown and Williamson documents. JAMA 274 248 253

28. BarnoyaJ

GlantzS

2002 Tobacco industry success in preventing regulation of secondhand smoke in Latin America: The “Latin Project”. Tob Control 11 305 314

29. BarnoyaJ

GlantzS

2005 The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur J Public Health 16 69 77

30. BeroL

2003 Implications of the tobacco industry documents for public health policy. Annu Rev Public Health 24 267 288

31. BeroL

2005 Tobacco industry manipulation of research. Public Health Rep 120 200 208

32. BeroL

GalbraithA

RennieD

1994 Sponsored symposia on environmental tobacco smoke. JAMA 271 612 617

33. HirschhornN

BialousS

2001 Secondhand smoke and risk assessment: What was in it for the tobacco industry? Tob Control 10 375 382

34. HongM-K

BeroLA

2002 How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ 325 1413 1416

35. MuggliME

ForsterJ

HurtRD

RepaceJ

2001 The smoke you don't see: Uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am J Public Health 91 1419 1423

36. OngE

GlantzS

2001 Constructing “sound science” and “good epidemiology”: Tobacco, lawyers, and public relations firms. Am J Public Health 91 1749 1757

37. SchotlandM

BeroLA

2002 Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Anal 22 131 140

38. United States Court of Appeals 2009 U.S.A. v. Philip Morris, et al. No. 06-5267. Available: http://pacer.cadc.uscourts.gov/docs/common/opinions/200905/06-5267-1181914.pdf. Accessed 25 June 2009

39. World Health Organization 2004 WHO framework convention on tobacco control. Available: http://www.who.int/fctc/en/index.html. Accessed 25 June 2009

40. Framework Convention on Tobacco Control Conference of the Parties 2008 Guidelines for implementation of Article 5.3: Guidelines on the protection of public health policies with respect to tobacco control from commercial and other vested interests. Available: http://www.who.int/fctc/guidelines/article_5_3/en/index.html. Accessed 25 June 2009

41. BlalockJ

BurgardJ

1963 Re: Tobacco Institute, Tobacco Industry Research Committee, and Hill & Knowlton. Brown and Williamson Tobacco Corporation. Available: http://legacy.library.ucsf.edu/tid/akc72d00. Accessed 25 June 2009

42. United States Supreme Court 1995 Rubin v. Coors Brewing Co., 514 U.S. 476. Available: http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl?court=us&vol=514&invol=476. Accessed 25 June 2009

43. SzymanczykM

2009 Letter to Henry Waxman endorsing Family Smoking Prevention and Tobacco Control Act. Available: http://energycommerce.house.gov/Press_111/20090304/hr1256_support.pdf. Accessed 25 June 2009

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2009 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#